Literature DB >> 25912904

Improvement of Predictive Value for Thromboembolic Risk by Incorporating Left Atrial Functional Parameters in the CHADS2 and CHA2DS2-VASc Scores.

Mi-Na Kim1, Su-A Kim, Jong-il Choi, Seoung-Mi Park, Sang Won Park, Young Hoon Kim, Wan Joo Shim.   

Abstract

The discriminative ability of the widely used CHADS2 and CHA2DS2-VASc scores for risk stratification of thromboembolism in atrial fibrillation (AF) is known as modest. Some echocardiographic parameters are known risk factors for thromboembolism. This study aimed to evaluate whether combining echocardiographic parameters with CHADS2 and CHA2DS2-VASc scores can improve the predictive power for embolic risk in AF.A total of 526 (F/M = 83/433, mean age = 57.6 ± 10.7 years) patients with non-valvular AF were enrolled. The predictability for left atrial (LA) thrombus or dense spontaneous echo contrast (SEC) using clinical scores or echocardiographic parameters or combining clinical scores and echocardiographic parameters was calculated and compared.Dense SEC or thrombus was present in 51 patients. The predicting powers of the CHADS2 and CHADS2-VASc scores for the presence of dense SEC or thrombus were modest (c-statistics 0.65 and 0.68, respectively, 95% confidence interval [CI] 0.61-0.69 and 0.64-0.74, respectively, both P < 0.001). Impaired LA function was the most descriptive predictor for the presence of thrombus or dense SEC among echocardiographic parameters. Combining impaired LA function (LA emptying fraction < 30%) with the CHADS2 and CHA2DS2-VASc scores showed the improvement of predictive power in detecting dense SEC or thrombus (c-statistics 0.78 and 95% CI 0.74-0.81 and c-statistics 0.77 and 95% CI 0.73-0.81, respectively, both P < 0.001).Adding LA functional markers to the CHADS2 or CHA2DS2-VASc score improved the predictive value of the presence of thrombus or dense SEC. In clinical situations, anticoagulation should be considered to prevent embolism in patients with low-risk scores when they have LA dysfunction.

Entities:  

Mesh:

Year:  2015        PMID: 25912904     DOI: 10.1536/ihj.14-380

Source DB:  PubMed          Journal:  Int Heart J        ISSN: 1349-2365            Impact factor:   1.862


  8 in total

1.  Correlation between plasma brain natriuretic peptide levels and left atrial appendage flow velocity in patients with non-valvular atrial fibrillation and normal left ventricular systolic function.

Authors:  Masahiko Harada; Satoshi Tabako; Yuichiro Fujii; Yuichi Takarada; Kyoko Hayashi; Hiroshi Ohara; Fumihiko Hara; Takanori Ikeda
Journal:  J Echocardiogr       Date:  2017-12-18

2.  Left Atrial Dysfunction, Fibrosis and the Risk of Thromboembolism in Patients With Paroxysmal and Persistent Atrial Fibrillation.

Authors:  Hee-Dong Kim; Dong-Hyuk Cho; Mi-Na Kim; Sung Ho Hwang; Jaemin Shim; Jong-Il Choi; Young-Hoon Kim; Seong-Mi Park
Journal:  Int J Heart Fail       Date:  2022-01-25

3.  Value of Combining Left Atrial Diameter and Amino-terminal Pro-brain Natriuretic Peptide to the CHA2DS2-VASc Score for Predicting Stroke and Death in Patients with Sick Sinus Syndrome after Pacemaker Implantation.

Authors:  Bin-Feng Mo; Qiu-Fen Lu; Shang-Biao Lu; Yu-Quan Xie; Xiang-Fei Feng; Yi-Gang Li
Journal:  Chin Med J (Engl)       Date:  2017-08-20       Impact factor: 2.628

4.  Non-vitamin K antagonist oral anticoagulants versus warfarin for the prevention of spontaneous echo-contrast and thrombus in patients with atrial fibrillation or flutter undergoing cardioversion: A trans-esophageal echocardiography study.

Authors:  Yun Gi Kim; Jong-Il Choi; Mi-Na Kim; Dong-Hyuk Cho; Suk-Kyu Oh; Hyungdon Kook; Hee-Soon Park; Kwang No Lee; Yong-Soo Baek; Seung-Young Roh; Jaemin Shim; Seong-Mi Park; Wan Joo Shim; Young-Hoon Kim
Journal:  PLoS One       Date:  2018-01-23       Impact factor: 3.240

5.  Association of CHADS2 and CHA2DS2-VASc Scores with Left Atrial Thrombus with Nonvalvular Atrial Fibrillation: A Single Center Based Retrospective Study in a Cohort of 2695 Chinese Subjects.

Authors:  J Huang; S L Wu; Y M Xue; H W Fei; Q W Lin; S Q Ren; H T Liao; X Z Zhan; X H Fang; L Xu
Journal:  Biomed Res Int       Date:  2017-03-08       Impact factor: 3.411

6.  Improving CHA2DS2-VASc stratification of non-fatal stroke and mortality risk using the Intermountain Mortality Risk Score among patients with atrial fibrillation.

Authors:  Benjamin D Horne; Thomas Jared Bunch; Kevin G Graves; Heidi T May; Kirk U Knowlton; Joseph B Muhlestein; Victoria Jacobs; Donald L Lappé; Jeffrey L Anderson
Journal:  Open Heart       Date:  2018-11-17

7.  Development and Validation of a Nomogram for Estimation of Left Atrial Thrombus or Spontaneous Echo Contrast Risk in Non-Valvular Atrial Fibrillation Patients with Low to Borderline CHA2DS2-VASc Score.

Authors:  Zhitong Li; Lifei Pan; Yawen Deng; Quanbo Liu; Tesfaldet H Hidru; Fei Liu; Chenglin Li; Tao Cong; Xiaolei Yang; Yunlong Xia
Journal:  Int J Gen Med       Date:  2022-09-18

8.  CHA2DS2-VASc Score as a Predictor for Left Atrial Thrombus or Spontaneous Echo Contrast in Patients with Nonvalvular Atrial Fibrillation: A Meta-Analysis.

Authors:  Ping Sun; Zhi Hao Guo; Hong Bin Zhang
Journal:  Biomed Res Int       Date:  2020-07-11       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.